Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumabPier Francesco Ferrucci, Chiara Martinoli, Paolo A. Ascierto et al.|Annals of Oncology|2016Cited by 398
Electrochemotherapy of superficial tumors – Current status:L Campana, Gregor Serša, Giulia Bertino et al.|Seminars in Oncology|2019Cited by 113
Prognostic and predictive value of β-blockers in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanomaOliver Kennedy, Mario Mandalà, Stéphane Dalle et al.|European Journal of Cancer|2022Cited by 51
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumabPier Francesco Ferrucci, Chiara Martinoli, Paolo A. Ascierto et al.|Annals of Oncology|2017Cited by 50